February is American Heart Month -- a time dedicated to raising awareness about heart disease, the leading cause of death in ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

Guthrie officials said that cardiovascular diseases are the leading killer in the United States, but there are steps that ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

One of the biggest challenges in managing AAA and PAD is the unpredictability of disease progression. For instance, while ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.

Black women face hidden risks of heart disease due to misdiagnosis and medical bias. The healthcare system must change to save lives.

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term ...